Calcium-modified microporous starch with potent hemostatic efficiency and excellent degradability for hemorrhage

Fangping Chen1, Xiaoyan Cao, Xiaolong Chen

  • 1The State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, P. R. China. fpchen@ecust.edu.cn liucs@ecust.edu.cn.

Insights

Calcium-modified microporous starch (CaMS) enhances hemostasis by activating coagulation and improving absorption. This novel hemostatic agent shows improved performance and degradability for severe bleeding control.

Area of Science:

  • Biomaterials Science
  • Trauma Care
  • Hemostatic Agents

Background:

  • Effective hemorrhage control is critical for reducing trauma-related mortality.
  • Microporous starch (MS) is a hemostatic agent with limited capacity for severe bleeding.
  • Improving hemostatic performance and degradability is essential for clinical applications.

Purpose of the Study:

  • To develop and evaluate calcium-modified microporous starch (CaMS) as an improved hemostatic agent.
  • To investigate the hemostasis efficiency and degradation behavior of CaMS.
  • To assess CaMS for controlling severe bleeding in preclinical models.

Main Methods:

  • Calcium modification of MS via oxidation and self-assembly with calcium ions (Ca2+).
  • Evaluation of hemostatic efficiency through absorption, swelling, coagulation cascade activation, and platelet adhesion.
  • Assessment of degradation behavior.
  • In vivo testing in rabbit liver and femoral artery injury models.

Main Results:

  • Successful modification of MS with carboxyl groups and Ca2+ to form CaMS.
  • CaMS demonstrated rapid absorption and swelling, similar to MS.
  • CaMS activated the intrinsic coagulation pathway and promoted platelet adhesion.
  • CaMS achieved effective hemorrhage control in rabbit injury models.
  • CaMS exhibited significantly improved degradation properties compared to MS.

Conclusions:

  • CaMS effectively enhances hemostatic performance and degradability.
  • The synergistic physical absorption and chemical activation mechanisms contribute to CaMS's efficacy.
  • CaMS is a promising candidate for developing advanced hemostatic agents for clinical use.